产品编号：G718462
产品规格：2.5mg
产品价格：面议
| 标准品编号: | G718462 |
| 名称: | N-Glycylglycine-13C4 |
| 别名: | Glycylglycine-13C4;18: PN: WO2012015910 SEQID: 19 Unclaimed Sequence; 1: PN: WO2010117786 PAGE: 166 Claimed Protein; 2-(Aminoacetamido)acetic-13C4 Acid; 221: PN: EP2161028 PAGE: 11 Claimed Protein; 31: PN: FR2860236 PAGE: 10 Claimed Protein; 36: PN: EP2204377 SEQID: 36 Claimed Protein; 36: PN: WO2010076654 SEQID: 36 Claimed Protein; 69: PN: US20110195077 SEQID: 14 Claimed Sequence; 6: PN: WO2013027191 SEQID: 14 Claimed Sequence; Diglycine; Diglycocoll; Gly2; Glycine Dipeptide; Glycylglycine-13C4; N-Glycylglycine-13C4; NSC 49346-13C4; α-Glycylglycine-13C4 |
| 参考CAS号: | Unlabelled: 556-50-3 |
| 分子式: | ¹³C₄H₇NO₄ |
| 分子量: | 137.07 |
| 种类: | Standards; Isotopic Labeled Analogues; Pharmaceutical/API Drug Impurities/Metabolites; |
| 应用: | N-Glycylglycine-13C4 is the labelled version of N-Glycylglycine which is a derivative of Glycine (G615990), a non-essential amino acid that enhances N-methyl-D-aspartate (NMDA) receptor mediated synaptic potentials in the neocortex of rats. Glycine is also being used as adjuvant therapy for the treatment of schizophrenia. |
| 参考文献 | |
